Non-Invasive Test for Urothelial Cancer Detection
The researchers found that UroSEEK was positive in 83% of those who developed Bladder Cancer
Combined with cytology, it detected 95% of patients who developed Bladder Cancer. Seventy-five percent of patients with upper tract urothelial cancer tested positive by UroSEEK, including 79% of those with non-invasive tumors. In 68% of urines obtained from Bladder Cancer patients under surveillance who demonstrated clinical evidence of recurrence, UroSEEK detected genetic abnormalities. In low-grade Bladder Cancers, UroSEEK detected 67% of cases, while none were detected by cytology.
These results establish the foundation for a new non-invasive approach for detection of urothelial cancer.
Send me a message if you have any question or make an appointment (toll-free: 800444444 or +971 4 520 0500)
Emirates Hospital, Jumeirah Beach Road, opposite Jumeirah Park (below the Dubai Canal Bridge Take the U-turn under the bridge to reach the entrance) - Dubai